Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Q1:18 Health Care Spending: $112.9 Billion
A total of $112.9 billion was spent to fund the 386 transactions reported in Q1:18, based on disclosed prices. Total spending was about 2% lower than the $115.1 billion reported in the previous quarter. The Other Services sector dominated the dollar side of deal making, accounting for 60% ($68.2 billion) of spending. A single deal accounted for 59% of the quarter’s total, as Cigna (NYSE: CI) announced its acquisition of Express Scripts Holdings (NYSE: ESRX) for $67 billion, including debt. Source: HealthCareMandA.com, April 2018 The Biotechnology sector made up 28% ($31.2 billion) of spending in the first quarter. Many of the deals were front-loaded into January, so their announcements... Read More »
Health Care M&A Weekly Deals, The Week Ending April 20, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Center for Discovery Cliffside Malibu Merger Biotechnology Acquirer Target Price Basilea Pharmaceutica International Limited Exclusive license to... Read More »
Home Health & Hospice Deals Up 50% in Q1:18
After three straight quarters of relatively low home health and hospice merger and acquisition activity, the first quarter of 2018 saw 21 publicly announced transactions. This was a 50% increase from the fourth quarter of 2017 (14 transactions), but just a 5% increase from the year-ago quarter (20 transactions), according to new data from HealthCareMandA.com. Only three of the 21 transactions in this year’s first quarter disclosed a price, and the total was a small $46.1 million. This was similar to last year’s first quarter total of $20.9 million, but not comparable to last year’s fourth quarter when nearly $4.1 billion was announced encompassing just two acquisitions. During the first... Read More »
Physician Medical Group Deals Stayed Strong in Q1:18
Physician medical group M&A activity was strong in the first quarter of 2018, according to new acquisition data from HealthCareMandA.com. The number of physician medical group acquisitions increased to 36 in the first quarter, up 9% from the 33 publicly announced acquisitions in the fourth quarter of 2017. Compared with the year-earlier quarter, when a recent record of 59 deals were reported, deal activity was down 39%. None of the transactions disclosed a purchase price. The most prolific buyers were MEDNAX, Inc. (NYSE: MD) and Eye Health South with three acquisitions each, followed by Anne Arundel Dermatology, Gauge Capital, Platinum Dermatology and Team Health, with two deals each.... Read More »
Takeda Takes Aim at Shire
Big Pharma deals are making a comeback. Or so it seems from the speculation around Shire plc (NASDAQ: SHPG). Japanese drug maker Takeda Pharmaceutical Co. (OTCQB: TKPYY) has been buzzing around the UK-based Shire for nearly a month, making bid after bid. It seemed to begin on April 16, when Shire sold its oncology business to the French drug maker Servier, for $2.4 billion in cash. In 2017, the 0ncology business generated revenues of $262 million. The total consideration represents a revenue multiple of 9.2x 2017 revenues. The acquisition gives Servier a direct commercial presence in the United States and boosts its presence in cancer. Servier’s products will be commercialized in the... Read More »
Q1:18 Health Care M&A Stays Strong
Health care merger and acquisition activity in the first quarter of 2018 kept pace with the previous quarter in 2017. Compared with the fourth quarter of 2017, deal volume increased 1%, to 386 transactions. However, deal volume was down 12% compared with the same quarter the year before. Combined spending in the first quarter reached $112.9 billion, a decrease of 2% compared with the nearly $115.0 billion spent in the previous quarter, according to HealthCareMandA.com. Thanks to the announcement of a multi-billion-dollar deal in Q1:18, deal value rose 90% compared with $59.6 billion spent in Q1:17. Health Care M&A Market – Deal Volume by Sector Source: HealthCareMandA,com, April 2018... Read More »
Health Care M&A Weekly Deals, The Week Ending April 13, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Summit BHC Cottonwood Tucson N/A Biotechnology Acquirer Target Price Alexion Pharmaceuticals, Inc. Wilson Therapeutics AB $855 million Promethera Biosciences Baliopharm AG N/A Novartis AG AveXis... Read More »
Sleep Disorders Make for Steady Business
For all the companies and remedies devoted to sleep disorders, it’s a wonder they haven’t been cured by now. The latest deal targeting a company focused on sleep apnea and other conditions was announced last week, on April 11. SleepScore Labs, a medical device company based in Carlsbad, California, acquired the Dutch technology company Sleep.ai for an undisclosed amount. SleepScore Labs was founded in 2016 and is a joint venture between Dr. Mehmet Oz, ResMed (NYSE: RMD) and Pegasus Capital Advisors. It is focused on improving sleep and uses ResMed’s SleepScore technology. ResMed specializes in cloud-connected devices for daily remote patient monitoring, to help treat and... Read More »
Humana Adds Physicians in Florida
Humana (NYSE: HUM) hasn’t made a lot of waves in the Physician Medical Group sector. Its larger managed care rival, UnitedHealth Group’s Optum (NYSE: UNH), spent approximately $8.2 billion on two large physician practice acquisitions in 2017 alone. There’s also the distraction of acquisition talks with one of the world’s largest retailers, Walmart (NYSE: WMT), which were revealed by The Wall Street Journal in April 2018. While those talks are ongoing, Humana is honing its Medicare and Medicare Advantage services with the recent acquisition of Family Physicians Group based in Orlando, Florida. Financial terms were not disclosed, but it’s a safe bet they were... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
